跳至主要内容
临床试验/NCT01889979
NCT01889979已完成3 期

Tramadol for Labour Analgesia in Low Risk Primiparous Women. Double Blind, Randomized, Controlled Trial.

Saint Thomas Hospital, Panama1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Pain during labour

研究概览

简要总结

Tramadol is a centrally acting synthetic analgesic used to treat moderate to moderately severe pain. It has been previously evaluated as a method to reduce pain during labour, but there is always some fear related to its effects (neonatal respiratory depression). The purpose of our study was to evaluate the efficacy of subcutaneous tramadol in regards to pain during labour, duration of labour and neonatal outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Gestational age between 37 and 40 6/7 weeks
  • Primiparous patient
  • Singleton
  • 4 to 5 cms of dilation
  • Intact membranes or spontaneous rupture of membranes less than 2 hours
  • Fetus in a vertex presentation
  • Gynecoid pelvis by clinical examination

排除标准

  • Multiparous
  • Multiple pregnancies
  • Any pathology
  • Induction of labour with prostaglandins

研究组 & 干预措施

Tramadol

Experimental

100 mg of tramadol SC (single dose) = 2 mL

干预措施: Tramadol (Drug)

Placebo

Placebo Comparator

2 mL of a sterile solution SC

干预措施: Placebo (Drug)

结局指标

主要结局

Pain during labour

时间窗: 6 hours

Pain during labour was evaluated using the Visual Analogue Scale during the first six hours after the application of the drug (tramadol or placebo).

次要结局

  • Duration of labour(12 hours)
  • Neonatal outcomes(48 hours)
  • Side effects(48 hours)
  • Requirements of oxytocin(12 hours)

研究者

发起方
Saint Thomas Hospital, Panama
申办方类型
Other
责任方
Principal Investigator
主要研究者

Osvaldo A. Reyes T.

Coordinator of Research

Saint Thomas Hospital, Panama

研究点 (1)

Loading locations...

相似试验

Tramadol for Labour Analgesia in Low Risk... | 临床试验